<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67042">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01791439</url>
  </required_header>
  <id_info>
    <org_study_id>11-201-SDR</org_study_id>
    <secondary_id>11-201-SDR</secondary_id>
    <nct_id>NCT01791439</nct_id>
  </id_info>
  <brief_title>Glossopharyngeal Nerve Blockade for Awake Videolaryngoscope Assisted Endotracheal Intubation in the Morbidly Obese</brief_title>
  <official_title>Glossopharyngeal Nerve Blockade for Awake Videolaryngoscope Assisted Endotracheal Intubation in the Morbidly Obese.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Victoria Hospital, Canada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royal Victoria Hospital, Canada</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators wish to determine if application of 2% lidocaine soaked gauze to the
      peritonsillar pillars will decrease the amount of gagging caused by awake videolaryngocope
      assisted tracheal intubation in the morbidly obese.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Gagging</measure>
    <time_frame>2 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess the amount of gagging during the awake intubation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>vital signs</measure>
    <time_frame>2 minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>we will asses vital signs during intubation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lidocaine levels</measure>
    <time_frame>40 minutes</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Gagging</condition>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will have gauze soaked with lidocaine applied to the peritonsillar pillars.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Application of saline to the glossopharyngeal nerve.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>lidocaine</intervention_name>
    <description>Application of lidocaine to the glossopharyngeal nerve.</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  morbid obese patients scheduled for bariatric surgery, with a planned awake
             intubation.

        Exclusion Criteria:

          -  inability to communicate in English or french

          -  allergies to any study drugs

          -  any patient with an American society of anesthesiologists score of 4 or more
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Albert Moore, md</last_name>
    <phone>5149341934</phone>
    <phone_ext>34880</phone_ext>
    <email>moore_albert@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal Victoria Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albert Moore, MD</last_name>
      <phone>5149341934</phone>
      <phone_ext>34880</phone_ext>
      <email>moore_albert@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>February 13, 2013</lastchanged_date>
  <firstreceived_date>February 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Royal Victoria Hospital, Canada</investigator_affiliation>
    <investigator_full_name>Albert Moore</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gagging</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
